ENDOMETROID ENDOMETRIAL CANCER

Clinical trials for ENDOMETROID ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new ENDOMETROID ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for ENDOMETROID ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted combo therapy tested for Tough-to-Treat uterine cancer

Disease control Ongoing

This study is testing whether a combination of two drugs, alpelisib and fulvestrant, can help control advanced endometrial cancer that has a specific genetic mutation (PIK3CA) and responds to estrogen. It is for people whose cancer has returned or spread and is not likely curable…

Matched conditions: ENDOMETROID ENDOMETRIAL CANCER

Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

ENDOMETROID ENDOMETRIAL CANCER

Get alerted when new ENDOMETROID ENDOMETRIAL CANCER trials appear

Targeted combo therapy tested for Tough-to-Treat uterine cancer